Sanofi

ACT Kids adds toothpaste to oral care line

ACT Kids adds toothpaste to oral care line

BRIDGEWATER, N.J. — Sanofi has launched ACT Kids Toothpaste, complementing the ACT brand’s lineup of oral rinses for children. Sanofi said ACT Kids Toothpaste is an anti-cavity fluoride toothpaste specially designed for children ages 2 and older. The toothpaste strengthens and protects developing teeth and helps prevent cavities. With ACT Kids Toothpaste’s Bubble Gum Blowout

Sanofi cleared to market OTC Xyzal allergy medicine

Sanofi cleared to market OTC Xyzal allergy medicine

BRIDGEWATER, N.J. — Sanofi is adding to its roster of prescription-to-OTC allergy medications with Xyzal Allergy 24HR. The Food and Drug Administration has approved Xyzal Allergy 24HR (levocetirizine dihydrochloride) as an over-the-counter treatment to alleviate symptoms of seasonal and year-round allergies, Sanofi said Wednesday. The product offers proven 24-hour relief from runny nose, sneezing, itchy

Sanofi, Boehringer agree to $25 billion asset swap

Sanofi, Boehringer agree to $25 billion asset swap

PARIS — Sanofi has agreed to a 22.8 billion euro ($25.1 billion) asset swap with Germany’s Boehringer Ingelheim GmbH that will boost the French drug manufacturer’s business in selling over-the-counter drugs. The two companies reached a definitive agreement late Monday after announcing exclusive negotiations in December. Terms are unchanged from the original announcement: Sanofi will